Search

everythinglearnresearchcommunity

for

Search:↓

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

A married couple both developed a rare type of hair loss, possibly due to shared environmental factors.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Early hair loss may predict heart disease.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride may improve prostate cancer treatment outcomes.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Testosterone is crucial for development, growth, and various body functions in mammals.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.